Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 1,161 HALO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/Award | 1,161 | n/a |
| Feb 9, 2026 | Generation Bio Co. (GBIO) | Tender of Shares | 1,263 | n/a |
| Jun 6, 2025 | Generation Bio Co. (GBIO) | Grant/Award | 30,000 | n/a |
| Jun 10, 2024 | Generation Bio Co. (GBIO) | Grant/Award | 60,000 | n/a |
| Dec 11, 2023 | Generation Bio Co. (GBIO) | Purchase | 637 | $1.2K |
| Dec 6, 2023 | Generation Bio Co. (GBIO) | Purchase | 12,000 | $18.0K |
| Jun 12, 2023 | Generation Bio Co. (GBIO) | Grant/Award | 25,000 | n/a |
| Jul 19, 2022 | Generation Bio Co. (GBIO) | Grant/Award | 38,400 | n/a |